Recently, Chairman Li Min of Guangzhou Royal Lee Cancer Hospital and his delegation visited Shenzhen Cell Valley for an exchange. The two parties engaged in in-depth discussions on key topics such as the development of cell therapy technology, the translation of clinical achievements, and overseas market expansion, exploring opportunities for collaboration. Shenzhen Cell Valley's Chairman Professor Shi Yuan Yuan and General Manager Tang Xiaomeng of Shenzhen-Hong Kong Cell Valley warmly received the delegation and hosted a productive seminar.

Marketing Director Sun Rui led the delegation on a tour of Shenzhen Cell Valley's R&D center and production base, providing a detailed introduction to the advanced facilities and innovative achievements in areas such as technology pipeline development and quality management system construction. During the visit, the guests highly praised the research environment, technological platforms, and industrialization capabilities of Cell Valley.

During the subsequent seminar, Chairman Professor Shi Yuan Yuan systematically introduced the development overview of Cell Valley Group, highlighting progress in government support, industry-academia collaboration, clinical translation, core technology and product layout, and overseas business expansion. Professor Shi Yuan Yuan emphasized that Cell Valley remains committed to innovation-driven growth, actively promoting the clinical translation and application of cell therapy technologies, and looks forward to deepening collaborations with more healthcare institutions.

In the exchange session, the two parties conducted constructive discussions on topics such as the global expansion of cell therapy business and collaboration opportunities in Southeast Asian markets. Chairman Li Min shared insights into the unique positioning and international development strategy of his institution in the field of oncology treatment. He also expressed clear intentions for collaboration, looking forward to exploring synergies with Cell Valley in areas such as technological complementarity and joint market expansion to achieve resource integration and mutual benefits.

This exchange laid a solid foundation for future pragmatic collaboration between the two parties. Shenzhen Cell Valley will continue to uphold the principles of openness and win-win cooperation, partnering with industry peers to drive the high-quality development of the cell therapy industry and contribute innovative solutions to global health.